
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f - 2
10 Demonstrated Tips to Expand Your New Android Cell phone: A Thorough Aide - 3
Eating Brie, Gouda, cheddar may lower dementia risk, new study says - 4
Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance - 5
Elite Execution Wall televisions for Film Darlings
Dominating the Art of Composing: Creator Bits of knowledge
PHOTO ESSAY: Summer camp for kids with autoimmune diseases
Most loved Public Dish: Which One Addresses Its Nation Best?
The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
Manual for Financial plan Agreeable PC
Poland Crypto Bill Clears Sejm Again, Defying President — Will “Restrictive” Rules Stick?
What’s your chronotype? Knowing whether you’re a night owl or an early bird could help you do better on tests and avoid scams
Venezuelans in Madrid celebrate Maduro's capture
Spotify Wrapped and Apple Music Replay are here: Top songs, albums and artists of 2025












